Advertisement

Medicinal Chemistry Research

, Volume 21, Issue 12, pp 4542–4548 | Cite as

Simultaneous LC determination of rosuvastatin, lisinopril, captopril, and enalapril in API, pharmaceutical dosage formulations, and human serum

  • M. Saeed Arayne
  • Najma Sultana
  • Arman TabassumEmail author
  • Saeeda Nadir Ali
  • Safila Naveed
Original Research

Abstract

A sensitive, economical, and rapid LC method for the quantification of CVD’s rosuvastatin, lisinopril, captopril, and enalapril in bulk drug, pharmaceutical dosage formulations and in human serum has been developed and validated. Chromatographic separation was performed by methanol:water (75:25 v/v) as mobile phase whose pH was adjusted to 3.0 by o-phosphoric acid; flowing at a rate of 1.0 mL min−1 through pre-packed Purospher Star C18 (5 μm, 25 × 0.46 cm) column at ambient temperature. UV detection was performed at isosbestic point 214 nm. The method shows good linearity in the range of 0.5–25 μg mL−1 for rosuvastatin (R 2 = 0.998) and 1–50 μg mL−1 for lisinopril, captopril and enalapril (R 2 = 0.999). All LOD values were ≤130 and LOQ ≤ 370 ng mL−1 for API and human serum. The % recoveries of all drugs were between 98.07 and 102.51% in dosage formulations and human serum. The ICH guidelines were followed for the validation of method. The method can be employed for pharmacokinetic studies, routine QC analysis of dosage formulations, and laboratory analysis in blood samples of high cholesterol and hypertension patients.

Keywords

Rosuvastatin Lisinopril Captopril Enalapril Liquid chromatography 

References

  1. Amini M, Zarghi A, Vatanpour H (1999) Sensitive high-performance liquid chromatographic method for determination of captopril in plasma. Pharm Acta Helv 73:303–330. http://www.sciencedirect.com/science/article/pii/S0031686599000072 Google Scholar
  2. Arayne MS, Sultana N, Mirza AZ, Shamshad H (2010) High-performance liquid chromatographic analysis of pioglitazone, gliquidone, rosuvastatin and simvastatin in formulations and human serum. Chin J Chem 28:1998–2002. http://onlinelibrary.wiley.com/doi/10.1002/cjoc.201090333/pdf
  3. Bibi R, Naqvi BS, Shoaib MH, Rahim N (2011) Design and evaluation of a new formulation of enalapril maleate tablet. Pak J Pharm Sci 24:211–215. http://76.162.69.21/CD-PJPS-24-2-11/Paper-18.pdf
  4. Carlucci G, Giuseppe ED, Mazzeo P (1993) Simultaneous determination of enalapril maleate and hydrochlorothiazide in tablets by derivative UV spectrophotometry and high-performance liquid chromatography. Intl J Pharm 93:245–248. http://www.sciencedirect.com/science/article/pii/037851739390184H Google Scholar
  5. Caslake MJ, Stewart G, Day SP, Daly E, McTaggart F, Chapman MJ, Durrington P, Laggner P, Mackness M, Pears J (2003) Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia. Atherosclerosis 171:245–253. http://www.sciencedirect.com/science/article/pii/S0021915003003654 Google Scholar
  6. Chaudhari BG, Patel NM, Shah PB (2007) Determination of simvastatin, pravastatin sodium and rosuvastatin calcium in tablet dosage forms by HPTLC. Indian J Pharma Sci 69: 130–132. http://ijpsonline.com/article.asp?issn=0250-474X;year=2007;volume=69;issue=1;spage=130;epage=132;aulast=Chaudhari Google Scholar
  7. El Walily AFM, Belal SF, Heaba EA, El Kersh A (1995) Simultaneous determination of enalapril maleate and hydrochlorothiazide by first-derivative ultraviolet spectrophotometry and high-performance liquid chromatography. J Pharm Biomed Anal 13:851–856. http://www.sciencedirect.com/science/article/pii/073170859501346M
  8. El-Emam AA, Hansen SH, Moustafa MA, El-Ashry SM, El-Sherbiny DT (2004) Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection. J Pharm Biomed Anal 34:35–44. http://www.sciencedirect.com/science/article/pii/S0731708503004965 Google Scholar
  9. El-Wasseef DR, El-Sherbiny DT, El-Enin MAA, El-Ashry SM (2011) Simultaneous in vitro HPLC determination of enalapril maleate and lercanidipine HCl. J Liq Chromatogr R T 34:48–60. http://www.tandfonline.com/doi/pdf/10.1080/10826076.2010.534411 Google Scholar
  10. Goodman LS, Gilman AG (1996) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, Health Professions Division, New YorkGoogle Scholar
  11. Huang T, He Z, Yang B, Shao L, Zheng X, Duan G (2006) Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution. J Pharm Biomed Anal 41:644-648. http://www.sciencedirect.com/science/article/pii/S0731708505007508 Google Scholar
  12. ICH Q2 (R1) (2005) Validation of analytical procedures: text and methodology. IFPMA, Geneva. http://private.ich.org/LOB/media/MEDIA417.pdf
  13. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW (2003) Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 92:152–160. http://www.sciencedirect.com/science/article/pii/S0002914903005307 Google Scholar
  14. Lan K, Jiang X, Li Y, Wang L, Zhou J, Jiang Q, Ye L (2007) Quantitative determination of rosuvastatin in human plasma by ion pair liquid–liquid extraction using liquid chromatography with electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 44: 540–546. http://www.sciencedirect.com/science/article/pii/S0731708507000131 Google Scholar
  15. McKenney JM (2005) Efficacy and safety of rosuvastatin in treatment of dyslipidemia. Am J Health-Syst Pharm 62:1033–1047. http://www.ajhp.org/content/62/10/1033.short Google Scholar
  16. Pasha MK, Muzeeb S, Basha SJS, Shashikumar D, Mullangi R, Srinivas NR (2006) Analysis of five HMG-CoA reductase inhibitors—atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Biomed Chromatogr 20:282–293. http://onlinelibrary.wiley.com/doi/10.1002/bmc.561/full Google Scholar
  17. Qin XZ, DeMarco J, Ip DP (1995) Simultaneous determination of enalapril, felodipine and their degradation products in the dosage formulation by reversed-phase high-performance liquid chromatography using a Spherisorb C8 column. J Chromatogr A 707:245–254. http://www.sciencedirect.com/science/article/pii/002196739500349R
  18. Siddiqui FA, Arayne MS, Sultana N, Qureshi F, Mirza AZ, Shehnaz H (2009) Quantitative determination of fluoroquinolonic antibiotics: pefloxacin, norfloxacin, ciprofloxacin and ofloxacin in pharmaceutical preparations and human serum by high-performance liquid chromatography using multi-wavelength calibration technique. Chem Anal (Warsaw) 54:1465–1485. http://cat.inist.fr/?aModele=afficheN&cpsidt=22644363 Google Scholar
  19. Sultana N, Arayne MS, Iftikhar B (2008) Simultaneous Determination of atenolol, rosuvastatin, spironolactone, glibenclamide and naproxen sodium in pharmaceutical formulations and human plasma by RP-HPLC. J Chin Chem Soc 5:1022–1029. http://proj3.sinica.edu.tw/~chem/servxx6/files/paper_2993_1268463823.pdf
  20. Sultana N, Arayne MS, Naveed S, Shamshad H (2009) An RP-HPLC method for simultaneous analysis of, and interaction studies on, enalapril maleate and H2-receptor antagonists. Acta Chromatogr 21:547–558. http://www.akademiai.com/content/d41k775k70n03203/?p=9969ad9ab40b448d84dc661509665eee&pi=2 Google Scholar
  21. Sultana N, Arayne MS, Shahzad W (2010a) Simultaneous determination of ceftriaxone sodium and statin drugs in pharmaceutical formulations and human serum by RP-HPLC. J Chil Chem Soc 55:193–198. http://www.scielo.cl/pdf/jcchems/v55n2/art10.pdf Google Scholar
  22. Sultana N, Arayne MS, Shafi N, Siddiqui FA, Hussain A (2010b) Development of a RP-HPLC method for the simultaneous analysis of diltiazem and statin: application in pharmaceuticals and human serum. Anal Methods 2:1571–1576 http://pubs.rsc.org/en/content/articlelanding/2010/ay/c0ay00337a
  23. Sultana N, Arayne MS, Naveed S (2010c) Simultaneous determination of captopril and statins in API, pharmaceutical formulations and in human serum by RP-HPLC. J Chin Chem Soc 57:378–383. http://proj3.sinica.edu.tw/~chem/servxx6/files/paper_13422_1278666001 Google Scholar
  24. Sultana N, Arayne MS, Naveed S (2010d) Simultaneous quantitation of captopril and NSAIDs in API, dosage formulations and human serum by RP-HPLC. J Chin Chem Soc 57:62–67. http://proj3.sinica.edu.tw/~chem/servxx6/files/paper_11137_1270711942.pdf Google Scholar
  25. Sultana N, Arayne MS, Naveed S (2011) Validated method for the simultaneous determination of lisinopril, pravastatin, atorvastatin and rosuvastatin in API, formulations and human serum by RP-HPLC. Chin J Chem 29:1216–1220. http://onlinelibrary.wiley.com/doi/10.1002/cjoc.201190226/pdf
  26. Tajerzadeh H, Hamidi M (2001) A simple HPLC method for quantitation of enalaprilat. J Pharm Biomed Anal 24:675–680. http://www.sciencedirect.com/science/article/pii/S0731708500004465 Google Scholar
  27. Tobert JA (2003) Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discovery 2:517–526. http://www.nature.com/nrd/journal/v2/n7/abs/nrd1112.html Google Scholar
  28. Tzvetkova D, Obreshkova D, Pencheva I (2005) HPLC analysis of lisinopril in tablets. Acta Pharm Turcica 47:179–187. http://www.actapharmasciencia.org/pdf/2005_vol47_no3-2.pdf Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • M. Saeed Arayne
    • 1
  • Najma Sultana
    • 1
  • Arman Tabassum
    • 2
    Email author
  • Saeeda Nadir Ali
    • 2
  • Safila Naveed
    • 3
  1. 1.United BiotechnologiesKarachiPakistan
  2. 2.Department of ChemistryUniversity of KarachiKarachiPakistan
  3. 3.Faculty of PharmacyJinnah University of WomenKarachiPakistan

Personalised recommendations